Recovery Benefit With Total Intravenous Anesthesia in Patients Receiving Rhinoplasty
Otolaryngology–Head and Neck Surgery · 2023
DOI: 10.1002/ohn.319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2023. Verfasst von Emily S Sagalow und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Propofol, Rhinoplasty, Anesthetics, Inhalation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Objective
The aim was to evaluate the difference in recovery when comparing total intravenous anesthesia (TIVA) to inhalational gas anesthesia in patients receiving rhinoplasty. Study Design Retrospective review.
Setting
Postoperative anesthesia care unit (PACU).
Methods
Patients who received a functional or cosmetic rhinoplasty at a single academic institution between April 2017 and November 2020 were included. Inhalational gas anesthesia was in the form of sevoflurane. Phase I recovery time, which was defined as the time it took a patient to reach ≥9/10 on the Aldrete scoring system was recorded, as well as the usage of pain medication in the PACU. The postoperative course and incidence of postoperative nausea and vomiting (PONV) were also collected.
Results
Two hundred and two patients were identified with 149 (73.76%) who received TIVA and 53 (26.24%) who received sevoflurane. For the patients who received TIVA, the average recovery time was 101.44 minutes (standard deviation [SD]: 34.64) compared to an average recovery time of 121.09 minutes (SD: 50.19) for patients who received sevoflurane leading to a difference of 19.65 minutes ( p = 0.002). Patients who received TIVA experienced less PONV ( p = 0.001). There were no differences in the postoperative course including surgical or anesthesia complications, postoperative complications, hospital or Emergency Department admissions, or administration of pain medication ( p > 0.05 for all).
Conclusion
When utilizing TIVA over inhalational anesthesia, patients undergoing rhinoplasty had significantly increased benefits in terms of reduced phase I recovery times and decreased incidence of PONV. TIVA was demonstrated to be a safe and efficacious method of anesthesia for this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Emily S Sagalow, Leonard E Estephan, Michelle Hwang, Howard Krein, Ryan Heffelfinger
Zitieren
APA
Sagalow, E. S., Estephan, L. E., Kumar, A. T., Hwang, M., Krein, H., & Heffelfinger, R. (2023). Recovery Benefit With Total Intravenous Anesthesia in Patients Receiving Rhinoplasty. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.319
Vancouver
Sagalow ES, Estephan LE, Kumar AT, Hwang M, Krein H, Heffelfinger R. Recovery Benefit With Total Intravenous Anesthesia in Patients Receiving Rhinoplasty. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.319
BibTeX
@article{Sagalow2023,
author = {Sagalow, Emily S and Estephan, Leonard E and Kumar, Ayan T and Hwang, Michelle and Krein, Howard and Heffelfinger, Ryan},
title = {Recovery Benefit With Total Intravenous Anesthesia in Patients Receiving Rhinoplasty},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
doi = {10.1002/ohn.319}
}
EUVIMED